Who invested in Tome Biosciences?
Tome Biosciences's investors include Andreessen Horowitz, Google Ventures, Polaris Partners, ARCH Venture Partners and Longwood Fund.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$213Mraised across 1 round since 2023, from 1 source
Source recorded
Tome Biosciences's investors include Andreessen Horowitz, Google Ventures, Polaris Partners, ARCH Venture Partners and Longwood Fund.
Tome Biosciences has raised $213M across 1 round since 2023.
Tome Biosciences's most recent round was a Series A of $213M in Dec 2023.
Its most recent round, $213M in Dec 2023, is also its largest on record.
Tome Biosciences's first round on record, in Dec 2023, was backed by Andreessen Horowitz, Google Ventures and Polaris Partners and 2 others.
Tome Biosciences's latest named round is a Series A, in Dec 2023.
Tome Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.